111 Price to Sales Ratio 2018-2024 | YI
111 P/S Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
2025-02-07 | 6.98 | 0.03 | |
2024-09-30 | 0.76 | $241.16 | 0.00 |
2024-06-30 | 1.07 | $240.89 | 0.00 |
2024-03-31 | 1.16 | $242.97 | 0.00 |
2023-12-31 | 1.55 | $250.23 | 0.01 |
2023-09-30 | 2.60 | $248.64 | 0.01 |
2023-06-30 | 2.46 | $245.69 | 0.01 |
2023-03-31 | 2.65 | $243.07 | 0.01 |
2022-12-31 | 3.02 | $235.30 | 0.01 |
2022-09-30 | 2.68 | $235.75 | 0.01 |
2022-06-30 | 2.06 | $241.86 | 0.01 |
2022-03-31 | 2.66 | $243.92 | 0.01 |
2021-12-31 | 3.50 | $235.18 | 0.01 |
2021-09-30 | 6.17 | $222.39 | 0.03 |
2021-06-30 | 9.09 | $202.02 | 0.04 |
2021-03-31 | 13.80 | $173.39 | 0.08 |
2020-12-31 | 6.95 | $152.64 | 0.05 |
2020-09-30 | 6.20 | $120.68 | 0.05 |
2020-06-30 | 6.35 | $97.40 | 0.07 |
2020-03-31 | 6.61 | $84.45 | 0.08 |
2019-12-31 | 6.73 | $69.33 | 0.10 |
2019-09-30 | 4.87 | $61.90 | 0.08 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.057B | $2.105B |
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $38.872B | 57.28 |
Tempus AI (TEM) | United States | $10.232B | 0.00 |
Hims & Hers Health (HIMS) | United States | $8.842B | 224.83 |
Inspire Medical Systems (INSP) | United States | $5.430B | 169.35 |
IRhythm Technologies (IRTC) | United States | $3.397B | 0.00 |
Privia Health (PRVA) | United States | $2.723B | 226.90 |
Enovis (ENOV) | United States | $2.544B | 16.95 |
Azenta (AZTA) | United States | $2.469B | 114.98 |
Clover Health Investments (CLOV) | United States | $2.225B | 0.00 |
Schrodinger (SDGR) | United States | $1.886B | 0.00 |
Omnicell (OMCL) | United States | $1.826B | 39.83 |
10x Genomics (TXG) | United States | $1.773B | 0.00 |
Phreesia (PHR) | United States | $1.680B | 0.00 |
Butterfly Network (BFLY) | United States | $0.937B | 0.00 |
Talkspace (TALK) | United States | $0.608B | 0.00 |
Standard BioTools (LAB) | United States | $0.529B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.507B | 0.00 |
TruBridge (TBRG) | United States | $0.380B | 110.57 |
Nyxoah SA (NYXH) | Belgium | $0.369B | 0.00 |
Health Catalyst (HCAT) | United States | $0.334B | 0.00 |
Pulmonx (LUNG) | United States | $0.254B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
American Well (AMWL) | United States | $0.176B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.104B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.087B | 0.00 |
P3 Health Partners (PIII) | United States | $0.073B | 0.00 |
CareCloud (CCLD) | United States | $0.066B | 0.00 |
HeartBeam (BEAT) | United States | $0.065B | 0.00 |
Zepp Health (ZEPP) | China | $0.045B | 0.00 |
Outset Medical (OM) | United States | $0.043B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.043B | 0.00 |
Zhongchao (ZCMD) | China | $0.037B | 0.00 |
Movano (MOVE) | United States | $0.035B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
MSP Recovery (MSPR) | United States | $0.019B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.016B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
Syra Health (SYRA) | United States | $0.005B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |